Association between serum lipids and survival in hemodialysis patients and impact of race

Posted by:

Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K.  J Am Soc Nephrol. 2007;18:293-303. Read more

Serum and dialysate potassium concentrations and survival in hemodialysis patients

Posted by:

Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K. Clin J Am Soc Nephrol. 2007;2:999-1007. Read more

Garenoxacin pharmacokinetics in subjects with renal impairment

Posted by:

Krishna G, Gajjar D, Swan S, Marbury T, Grasela DM, Wang Z.  Curr Med Res Opin. 2007;23(3):649-657. Read more

Impact of kidney bone disease and its management on survival of patients on dialysis

Posted by:

Lee GH, Benner D, Regidor DL, Kalantar-Zadeh K.  J Ren Nutr. 2007;17: 38-44. Read more

Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment

Posted by:

Noveck RJ, Preston RA, Swan SK. Clin Pharmacokinet. 2007;46(6):525-534. Read more

Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment

Posted by:

Swan SK, Smith WB, Marbury TC, Schumacher M, Dougherty C, Mico BA, Villano SA. J Clin Pharmacol. 2007;47(2):209-217. Read more

Pharmacokinetics of telbivudine in subjects with various degrees of renal impairment

Posted by:

Zhou XJ, Swan S, Smith WB, Marbury TC, Dubuc-Patrick G, Chao GC, Brown NA.  Antimicrob Agents Chemother. 2007;51(12):4231-4235. Read more

Phase I dose escalation study to evaluate the safety and pharmacokinetic profile of tefibazumab in subjects with end-stage renal disease requiring hemodialysis

Posted by:

Hetherington S, Texter M, Wenzel E, Patti JM, Reynolds L, Shamp T, Swan S. Antimicrob Agents Chemother. 2006;50(10):3499-3500. Read more

Serum myeloperoxidase and mortality in maintenance hemodialysis patients

Posted by:

Kalantar-Zadeh K, Brennan ML, Hazen SL. Am J Kidney Dis. 2006;48(1):59-68. Read more

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

Posted by:

Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD. Kidney Int. 2006;70:771-780. Read more